Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial
SourceBone Marrow Transplantation, 17, iss, 6, (1996), pp. 993-1001
Article / Letter to editor
Display more detailsDisplay less details
Bone Marrow Transplantation
iss. iss, 6
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.